Avalo Therapeutics (AVTX) Gross Profit Growth (1y) (2018 - 2024)
Avalo Therapeutics (AVTX) Gross Profit Growth (1y) (2018 - 2024) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Gross Profit Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 128.13 Bn | 120.28 Bn | 2.84 Bn | 11.24% |
| 2 | Regeneron Pharmaceuticals | 112.33 Bn | 104.33 Bn | 3.93 Bn | 15.59% |
| 3 | Argenx Se | 53.24 Bn | 48.05 Bn | 1.41 Bn | 68.41% |
| 4 | Revolution Medicines | 43.64 Bn | 43.64 Bn | - | - |
| 5 | BeOne Medicines | 39.27 Bn | 34.17 Bn | 1.53 Bn | 33.01% |
| 6 | MindWalk Holdings | 35.32 Bn | 35.31 Bn | 1.82 Bn | -41.93% |
| 7 | Royalty Pharma | 33.72 Bn | 35.84 Bn | - | - |
| 8 | Alnylam Pharmaceuticals | 30.58 Bn | 27.27 Bn | 992.69 Mn | 57.16% |
| 9 | Insmed | 27.01 Bn | 25.85 Bn | 358.27 Mn | 351.57% |
| 10 | Avalo Therapeutics | 854.16 Mn | 453.89 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Sep 30, 2024 | -4,127.27% |
| Jun 30, 2024 | -427.69% |
| Mar 31, 2024 | -5.26% |
| Dec 31, 2023 | 186.96% |
| Sep 30, 2023 | -100.08% |
| Jun 30, 2023 | 87.83% |
| Mar 31, 2023 | -116.78% |
| Dec 31, 2022 | 234.63% |
| Sep 30, 2022 | 3,162.67% |
| Jun 30, 2022 | -116.32% |
| Mar 31, 2022 | 14.39% |
| Dec 31, 2021 | -114.46% |
| Sep 30, 2021 | -57.25% |
| Jun 30, 2021 | 159.68% |
| Mar 31, 2021 | -85.27% |
| Dec 31, 2020 | -51.93% |
| Sep 30, 2020 | -50.02% |
| Jun 30, 2020 | 1,403.31% |
| Mar 31, 2020 | 47.38% |
| Dec 31, 2019 | 170.62% |